Asia-Pacific Sleep Disorder Market Databank
The Sleep Disorder market was valued at $13,700.0 Million in 2020, and is projected to reach $24,896.6 Million by 2029 growing at a CAGR of 6.91% from 2021 to 2029. Sleep apnea segment is expected to be the highest contributor to this market, with $5,274.6 Million in 2020, and is anticipated to reach $9,604.4 Million by 2029, registering a CAGR of 6.93%. Narcolepsy segment is anticipated to reach $5,510.9 Million by 2029 with the highest CAGR of 7.02%. Sleep apnea and Narcolepsy segments collectively expected to account for about 60.4% share of the Sleep Disorder market in 2020, with the former constituting around 38.5% share. Narcolepsy and Sleep apnea segments are expected to witness significant growth rates at a CAGR of 7.02% and 6.93% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 60.4% in the overall Sleep Disorder market in 2020, and is anticipated to reach 60.7% by 2029.
The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.
- 1. GLOBAL SLEEP DISORDER MARKET, BY DISORDER TYPE
- 1.1. OVERVIEW
- 1.2. SLEEP APNEA
- 1.2.1 SLEEP APNEA MARKET, BY REGION
- 1.2.1.1 North America Sleep apnea Market, By Country
- 1.2.1.2 Europe Sleep apnea Market, By Country
- 1.2.1.3 Asia-Pacific Sleep apnea Market, By Country
- 1.2.1.4 Rest of World Sleep apnea Market, By Country
- 1.3. INSOMNIA
- 1.3.1 INSOMNIA MARKET, BY REGION
- 1.3.1.1 North America Insomnia Market, By Country
- 1.3.1.2 Europe Insomnia Market, By Country
- 1.3.1.3 Asia-Pacific Insomnia Market, By Country
- 1.3.1.4 Rest of World Insomnia Market, By Country
- 1.4. RESTLESS LEGS SYNDROME (RLS)
- 1.4.1 RESTLESS LEGS SYNDROME (RLS) MARKET, BY REGION
- 1.4.1.1 North America Restless legs syndrome (RLS) Market, By Country
- 1.4.1.2 Europe Restless legs syndrome (RLS) Market, By Country
- 1.4.1.3 Asia-Pacific Restless legs syndrome (RLS) Market, By Country
- 1.4.1.4 Rest of World Restless legs syndrome (RLS) Market, By Country
- 1.5. NARCOLEPSY
- 1.5.1 NARCOLEPSY MARKET, BY REGION
- 1.5.1.1 North America Narcolepsy Market, By Country
- 1.5.1.2 Europe Narcolepsy Market, By Country
- 1.5.1.3 Asia-Pacific Narcolepsy Market, By Country
- 1.5.1.4 Rest of World Narcolepsy Market, By Country
- 1.6. OTHER DISORDER TYPES
- 1.6.1 OTHER DISORDER TYPES MARKET, BY REGION
- 1.6.1.1 North America Other Disorder Types Market, By Country
- 1.6.1.2 Europe Other Disorder Types Market, By Country
- 1.6.1.3 Asia-Pacific Other Disorder Types Market, By Country
- 1.6.1.4 Rest of World Other Disorder Types Market, By Country
- 2. GLOBAL SLEEP DISORDER MARKET, BY PRODUCT
- 2.1. OVERVIEW
- 2.2. DIAGNOSTICS
- 2.2.1 DIAGNOSTICS MARKET, BY REGION
- 2.2.1.1 North America Diagnostics Market, By Country
- 2.2.1.2 Europe Diagnostics Market, By Country
- 2.2.1.3 Asia-Pacific Diagnostics Market, By Country
- 2.2.1.4 Rest of World Diagnostics Market, By Country
- 2.3. THERAPEUTICS
- 2.3.1 THERAPEUTICS MARKET, BY REGION
- 2.3.1.1 North America Therapeutics Market, By Country
- 2.3.1.2 Europe Therapeutics Market, By Country
- 2.3.1.3 Asia-Pacific Therapeutics Market, By Country
- 2.3.1.4 Rest of World Therapeutics Market, By Country
- 3. GLOBAL SLEEP DISORDER MARKET, BY REGION
- 3.1. OVERVIEW
- 3.2. ASIA-PACIFIC
- 3.2.1 ASIA-PACIFIC SLEEP DISORDER MARKET, BY DISORDER TYPE
- 3.2.2 ASIA-PACIFIC SLEEP DISORDER MARKET, BY PRODUCT
- 3.2.3 ASIA-PACIFIC SLEEP DISORDER MARKET, BY COUNTRY
- 3.2.3.1 China
- 3.2.3.1.1 China Sleep Disorder Market, By Disorder Type
- 3.2.3.1.2 China Sleep Disorder Market, By Product
- 3.2.3.2 India
- 3.2.3.2.1 India Sleep Disorder Market, By Disorder Type
- 3.2.3.2.2 India Sleep Disorder Market, By Product
- 3.2.3.3 Japan
- 3.2.3.3.1 Japan Sleep Disorder Market, By Disorder Type
- 3.2.3.3.2 Japan Sleep Disorder Market, By Product
- 3.2.3.4 Australia
- 3.2.3.4.1 Australia Sleep Disorder Market, By Disorder Type
- 3.2.3.4.2 Australia Sleep Disorder Market, By Product
- 3.2.3.5 South Korea
- 3.2.3.5.1 South Korea Sleep Disorder Market, By Disorder Type
- 3.2.3.5.2 South Korea Sleep Disorder Market, By Product
- 3.2.3.6 Rest of Asia
- 3.2.3.6.1 Rest of Asia Sleep Disorder Market, By Disorder Type
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook